Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report) today and set a price target of ...

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

BRIDGEWATER, N.J., January 23, 2025--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved memantine ...

JP Morgan has recently raised Amneal Pharmaceuticals Inc (AMRX) stock to Neutral rating, as announced on September 6, 2024, according to Finviz. Earlier, on April 7, 2021, RBC Capital Mkts had resumed ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a ...

⚠ Beware of fake job offers claiming to be from Amneal Pharmaceuticals Pvt. Ltd. or Companies under Amneal Group (collectively referred to as “AMNEAL”). Amneal neither sends job offers from ...

$210,000 of AMNEAL PHARMACEUTICALS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Addressing drug shortages and ...